The stock of Lantheus Holdings Inc (NASDAQ:LNTH) reached all time high today, Nov, 14 and still has $29.52 target or 188.00% above today’s $10.25 share price. This indicates more upside for the $381.68M company. This technical setup was reported by Barchart.com. If the $29.52 PT is reached, the company will be worth $717.56M more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events. About 598,328 shares traded hands or 30.72% up from the average. Lantheus Holdings Inc (NASDAQ:LNTH) has risen 423.94% since April 12, 2016 and is uptrending. It has outperformed by 418.95% the S&P500.
Lantheus Holdings Inc (NASDAQ:LNTH) Ratings Coverage
Out of 5 analysts covering Lantheus Holdings (NASDAQ:LNTH), 2 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 40% are positive. Lantheus Holdings has been the topic of 9 analyst reports since August 31, 2015 according to StockzIntelligence Inc. The firm has “Neutral” rating by Robert W. Baird given on Monday, August 31. On Friday, September 23 the stock rating was initiated by Credit Suisse with “Neutral”. Credit Suisse downgraded the shares of LNTH in a report on Friday, December 11 to “Neutral” rating. The stock has “Outperform” rating given by RBC Capital Markets on Wednesday, February 24. The rating was maintained by Jefferies with “Buy” on Monday, August 29. On Wednesday, September 30 the stock rating was downgraded by Wells Fargo to “Market Perform”.
According to Zacks Investment Research, “Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States.”
More important recent Lantheus Holdings Inc (NASDAQ:LNTH) news were published by: Marketwatch.com which released: “Plus the latest data from Realtor.com on 21 home markets across the US” on July 30, 2014, also Fool.com published article titled: “Why Lantheus Holdings Inc. Sold Lower Friday”, Businesswire.com published: “Lantheus Holdings, Inc. Announces Public Offering of 5200000 Shares of Common …” on September 08, 2016. More interesting news about Lantheus Holdings Inc (NASDAQ:LNTH) was released by: Businesswire.com and their article: “Lantheus Holdings, Inc. Reports 2016 Second Quarter Financial Results” with publication date: August 04, 2016.
LNTH Company Profile
Lantheus Holdings, Inc., incorporated on November 30, 2007, develops, makes and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. The Company’s portfolio of approximately 10 commercial products is spread across a range of imaging modalities. The Company’s contrast agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging or magnetic resonance imaging (MRI), which are used by physicians to progress the clarity of the diagnostic image. Radiopharmaceuticals are radioactive pharmaceuticals used by clinicians to perform nuclear imaging procedures. The Company’s imaging agents include contrast agents and medical radiopharmaceuticals (including technetium generators), including DEFINITY, TechneLite, Xenon Xe 133 Gas (Xenon), Cardiolite and Neurolite.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.